학술논문
Preliminary results of a phase II randomized study to determine the efficacy and safety of genetically engineered allogeneic human chondrocytes expressing TGF-β1 in patients with grade 3 chronic degenerative joint disease of the knee
Document Type
Article
Author
Source
In: Osteoarthritis and Cartilage . (Osteoarthritis and Cartilage, In Press, December 30, 2014)
Subject
Language
English
ISSN
15229653
10634584
10634584